ProShares UltraShort Nasdaq Biotechnology (BIS)
| Assets | $2.37M |
| Expense Ratio | 0.95% |
| PE Ratio | n/a |
| Shares Out | 281,096 |
| Dividend (ttm) | $0.50 |
| Dividend Yield | 5.91% |
| Ex-Dividend Date | Dec 24, 2025 |
| Payout Ratio | n/a |
| 1-Year Return | -49.47% |
| Volume | 5,929 |
| Open | 8.50 |
| Previous Close | 8.56 |
| Day's Range | 8.41 - 8.50 |
| 52-Week Low | 8.31 |
| 52-Week High | 25.87 |
| Beta | -1.31 |
| Holdings | 6 |
| Inception Date | Apr 8, 2010 |
About BIS
Fund Home PageThe ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 24, 2025 | $0.10257 | Dec 31, 2025 |
| Sep 24, 2025 | $0.15427 | Sep 30, 2025 |
| Jun 25, 2025 | $0.10805 | Jul 1, 2025 |
| Mar 26, 2025 | $0.13255 | Apr 1, 2025 |
| Dec 23, 2024 | $0.20639 | Dec 31, 2024 |
| Sep 25, 2024 | $0.15181 | Oct 2, 2024 |
News
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discoun...
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...
Purchase Levels Of 31 Short ETFs Signal Bear Market Bottom (Technical Analysis)
We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.